Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C

Technology appraisal guidance
Reference number: TA75
Published: 28 January 2004
Last updated: 27 November 2013

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - decision paper presented to the Institute's Guidance Executive

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - decision paper presented to the Institute's Guidance Executive

TA75 Hepatitis C - pegylated interferons, ribavirin and alfa interferon: Appendix A - decision paper presented to the Institute's Guidance Executive
20 December 2013
(111.64 Kb 32 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 December 2013